Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wilate in surgical procedures for inherited von Willebrand disease
2010-021162-30Phase 3Completed
- Sponsor
- Octapharma
- Start
- Dec 2011
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of von Willebrand factor concentrate in von Willebrand disease (VWD), sponsored by Octapharma. Primary endpoint: Overall hemostatic efficacy. Started Dec 2011; status: completed.
02
Drugs
von Willebrand factor concentrate
03
Conditions
von Willebrand disease (VWD)
Beyond the preview
Go deeper on 2010-021162-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021162-30.